CPT1A: the future of heart disease detection and personalized medicine?

References

• Bonnefont JP, Demaugre F, Prip‑Buus C et al. Carnitine palmitoyltransferase deficiencies. Mol. Genet. Metab. 68, 424–440 (1999).
   Google Scholar
• McGarry JD, Brown NF. The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. Eur. J. Biochem. 244, 1–14 (1997).
   Google Scholar
• Bonnefont JP, Djouadi F, Prip‑Buus C, Gobin S, Munnich A, Bastin J. Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects. Mol. Aspects Med. 25, 495–520 (2004).
   Google Scholar
• Borch L, Lund AM, Wibrand F et al. Normal levels of plasma free carnitine and acylcarnitines in follow‑up samples from a presymptomatic case of carnitine palmitoyl transferase 1 (CPT1) deficiency detected through newborn screening in Denmark. JIMD Rep. 3, 11–15 (2012).
   Google Scholar
• Sim KG, Wiley V, Carpenter K, Wilcken B. Carnitine palmitoyltransferase i deficiency in neonate identified by dried blood spot free carnitine and acylcarnitine profile. J. Inherit. Metab. Dis. 24, 51–59 (2001).
   Google Scholar
• Bennett MJ, Boriack RL, Narayan S, Rutledge SL, Raff ML. Novel mutations in CPT 1A define molecular heterogeneity of hepatic carnitine palmitoyltransferase I deficiency. Mol. Genet. Metab. 82, 59–63 (2004).
   Google Scholar
• Rajakumar C, Ban MR, Cao H, Young TK, Bjerregaard P, Hegele RA. Carnitine palmitoyltransferase IA polymorphism p479l is common in greenland inuit and is associated with elevated plasma apolipoprotein A‑I. J. Lipid Res. 50, 1223–1228 (2009).
   Google Scholar
• Lemas DJ, Wiener HW, O’Brien DM et al. Genetic polymorphisms in carnitine palmitoyltransferase 1a gene are associated with variation in body composition and fasting lipid traits in Yup’ik Eskimos. J. Lipid Res. 53, 175–184 (2012).
   Google Scholar
• Robitaille J, Houde A, Lemieux S, Pérusse L, Gaudet D, Vohl MC. Variants within the muscle and liver isoforms of the carnitine palmitoyltransferase I (CPT1) gene interact with fat intake to modulate indices of obesity in French–Canadians. J. Mol. Med. (Berl.) 85, 129–137 (2007).
   Google Scholar
• Tripodi G, Modica R, Stella A, Bigatti G, Bianchi G, Stella P. Haplotype analysis of carnitine transporters and left ventricular mass in human essential hypertension. J. Ren. Nutr. 15, 2–7 (2005).
   Google Scholar
• Voruganti VS, Higgins PB, Ebbesson SO et al. Variants in CPT1A, FADS1, and FADS2 are associated with higher levels of estimated plasma and erythrocyte delta‑5 desaturases in Alaskan Eskimos. Front. Genet. 3, 86 (2012).
   Google Scholar
• Hirota Y, Ohara T, Zenibayashi M et al. Lack of association of CPT1A polymorphisms or haplotypes on hepatic lipid content or insulin resistance in Japanese individuals with Type 2 diabetes mellitus. Metabolism 56, 656–661 (2007).
   Google Scholar
• Teslovich TM, Musunuru K, Smith AV et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466, 707–713 (2010).
   Google Scholar
• Marian AJ. Elements of ‘missing heritability’. Curr. Opin. Cardiol. 27, 197–201 (2012).
   Google Scholar
• Zaina S, Lund G. Epigenetics: a tool to understand diet‑related cardiovascular risk? J. Nutrigenet. Nutrigenomics 4, 261–274 (2011).
   Google Scholar
• Irvin MR, Kabagambe EK, Tiwari HK et al. Apolipoprotein E polymorphisms and postprandial triglyceridemia before and after fenofibrate treatment in the Genetics of Lipid Lowering and Diet Network (GOLDN)Study. Circ. Cardiovasc. Genet. 3, 462–467 (2010).
   Google Scholar
• Sandoval J, Heyn H, Moran S et al. Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome. Epigenetics 6, 692–702 (2011).
   Google Scholar
• Adalsteinsson BT, Gudnason H, Aspelund T et al. Heterogeneity in white blood cells has potential to confound DNA methylation measurements. PLoS ONE 7, e46705 (2012).
   Google Scholar
• Bouwens M, Afman LA, Muller M. Activation of peroxisome proliferator‑activated receptor alpha in human peripheral blood mononuclear cells reveals an individual gene expression profile response. BMC Genomics 9, 262 (2008).
   Google Scholar
• Chinetti G, Fruchart JC, Staels B. Peroxisome proliferator‑activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation. Inflamm. Res. 49, 497–505 (2000).
   Google Scholar
• Aslibekyan S, Irvin MR, Sha J et al. CPT1A methylation is a novel epigenetic marker of cardiovascular risk. Presented at: American Heart Association Emerging Science Series. American Heart Association, Dallas, TX, USA, 18 June 2013.
   Google Scholar
• Hidalgo B, Irvin MR, Sha J et al. Epigenome‑wide association study of fasting measures of glucose, insulin, and HOMA‑IR in GOLDN. Diabetes doi:10.2337/db13‑1100 (2013) (epub ahead of print).
   Google Scholar